The average P/S ratio for ELV's competitors is 0.44, providing a benchmark for relative valuation. Elevance Health Inc Corp (ELV) exhibits a P/S ratio of 0.50, which is 14.74% above the industry average. Given its robust revenue growth of 6.55%, this premium appears unsustainable.